|
|
Adam Grundhoff, Don Ganem
J Clin Invest. 2004;
113(1):124
doi:10.1172/JCI17803
Abstract |
Full text
| PDF

K
aposi sarcoma–associated (KS-associated) herpesvirus (KSHV) infection is linked to the development of both KS and several lymphoproliferative diseases. In all cases, the resulting tumor cells predominantly display latent viral infection. KS tumorigenesis requires ongoing lytic viral replication as well, however, for reasons that are unclear but have been suggested to involve the production of angiogenic or mitogenic factors by lytically infected cells. Here we demonstrate that proliferating cells infected with KSHV in vitro display a marked propensity to segregate latent viral genomes, with only a variable but small subpopulation being capable of stable episome maintenance. Stable maintenance is not due to the enhanced production of viral or host trans-acting factors, but is associated with cis-acting, epigenetic changes in the viral chromosome. These results indicate that acquisition of stable KSHV latency is a multistep process that proceeds with varying degrees of efficiency in different cell types. They also suggest an additional role for lytic replication in sustaining KS tumorigenesis: namely, the recruitment of new cells to latency to replace those that have segregated the viral episome.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(16)
| Title and authors |
Publication |
Year |
Modulation of Interferon Regulatory Factor 5 Activities by the Kaposi Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3 Contributes to Immune Evasion and Lytic Induction
Xiaohui Bi, Lisong Yang, Margo E. Mancl, Betsy J. Barnes
|
Journal of Interferon & Cytokine Research
|
2011 |
Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8
T. Zhang, Y. Wang, L. Zhang, B. Liu, J. Xie, C. Wood, J. Wang
|
Journal of General Virology
|
2010 |
Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor
J Dwyer, A Le Guelte, E M Galan Moya, M Sumbal, A Carlotti, L Douguet, J S Gutkind, P A Grange, N Dupin, J Gavard
|
Oncogene
|
2010 |
Valganciclovir for Suppression of Human Herpesvirus–8 Replication: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Trial
Corey Casper, Elizabeth M. Krantz, Lawrence Corey, Steven R. Kuntz, Jie Wang, Stacy Selke, Shannon Hamilton, Meei‐Li Huang, Anna Wald
|
J INFECT DIS
|
2008 |
HIV/AIDS: Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma–Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease
Ryan J. Sullivan, Liron Pantanowitz, Corey Casper, Justin Stebbing, Bruce J. Dezube
|
CLIN INFECT DIS
|
2008 |
Oral manifestations associated with HIV infection
Mostafa Nokta
|
Curr HIV/AIDS Rep
|
2008 |
Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Denise Whitby, Vickie A Marshall, Rachel K Bagni, Wendell J Miley, Thomas G McCloud, Rebecca Hines-Boykin, James J Goedert, Betty A Conde, Kunio Nagashima, Judy Mikovits, Dirk P Dittmer, David J Newman
|
Int. J. Cancer
|
2007 |
Humanes Herpesvirus 8 (HHV-8) und Kaposi-Sarkom
C. Lebbé
|
Hautarzt
|
2007 |
The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma
P P Rose, J M Carroll, P A Carroll, V R DeFilippis, M Lagunoff, A V Moses, C T Roberts, K Früh
|
Oncogene
|
2006 |
Looking for the Target Cell of Kaposi's Sarcoma-Associated Herpesvirus
Nicolas Dupin, Philippe A Grange
|
J Investig Dermatol
|
2006 |
|